| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |